Inventor · disambiguated record
Gordon A. Vehar
Also filed as: VEHAR GORDON A
41 granted patents·1,680 citations·filing 1983–2001
98Inventor score
Files withGENENTECH INC41
Top patents by PatentIndex Score
41 records- 0198US4965199APreparation of functional human factor VIII in mammalian cells using methotrexate based selectionGENENTECH INC·Filed 1987·Granted Oct 23, 1990·624 cites·13 claims
- 0297US4766075AHuman tissue plasminogen activatorGENENTECH INC·Filed 1983·Granted Aug 23, 1988·298 cites·11 claims
- 0391US5589173AMethod and therapeutic compositions for the treatment of myocardial infarctionGENENTECH INC·Filed 1994·Granted Dec 31, 1996·124 cites·14 claims
- 0487US5668108APreparation of functional human factor VIII and pharmaceutical treatment therewithGENENTECH INC·Filed 1995·Granted Sep 16, 1997·35 cites·2 claims
- 0587US5618788APreparation of functional human factor VIII and pharmaceutical treatment therewithGENENTECH INC·Filed 1990·Granted Apr 8, 1997·42 cites·1 claims
- 0687US5346991ATissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disordersGENENTECH INC·Filed 1991·Granted Sep 13, 1994·56 cites·13 claims
- 0785US6274142B1Methods of neutralizing coagulation with anti-tissue factor antibodiesGENENTECH INC·Filed 1995·Granted Aug 14, 2001·60 cites·6 claims
- 0885US5633150APreparation of functional human factor VIIIGENENTECH INC·Filed 1990·Granted May 27, 1997·46 cites·6 claims
- 0981US6986894B2Methods for the treatment of coagulation disorders with lipoprotein associated coagulation inhibitor (LACI)GENENTECH INC·Filed 2001·Granted Jan 17, 2006·10 cites·7 claims
- 1081US4853330AHuman tissue plasminogen activatorGENENTECH INC·Filed 1988·Granted Aug 1, 1989·49 cites·15 claims
- 1180US5618789AFunctional human factor VIIIGENENTECH INC·Filed 1992·Granted Apr 8, 1997·27 cites·7 claims
- 1277US5739101ATissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disordersGENENTECH INC·Filed 1995·Granted Apr 14, 1998·23 cites·7 claims
- 1377US5589363ADNA encoding tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disordersGENENTECH INC·Filed 1994·Granted Dec 31, 1996·37 cites·16 claims
- 1477US5185259ATruncated human tissue plasminogen activatorGENENTECH INC·Filed 1990·Granted Feb 9, 1993·25 cites·1 claims
- 1577US5017556ATreatment of bleeding disorders using lipid-free tissue factor proteinGENENTECH INC·Filed 1989·Granted May 21, 1991·39 cites·15 claims
- 1672US5683905AVectors and cell lines capable of correctly splicing exon regionsGENENTECH INC·Filed 1995·Granted Nov 4, 1997·17 cites·6 claims
- 1765US5830448ACompositions and methods for the treatment of tumorsGENENTECH INC·Filed 1995·Granted Nov 3, 1998·22 cites·5 claims
- 1862US5753486AHuman tissue plasminogen activatorGENENTECH INC·Filed 1995·Granted May 19, 1998·8 cites·3 claims
- 1962US5112755APreparation of functional human urokinase proteinsGENENTECH INC·Filed 1988·Granted May 12, 1992·16 cites·15 claims
- 2062US5073494AHuman tissue plasminogen activator substituted at position 275 or at positions 275 and 277GENENTECH INC·Filed 1990·Granted Dec 17, 1991·20 cites·7 claims
- 2157US6284247B1Human tissue plasminogen activatorsGENENTECH INC·Filed 1998·Granted Sep 4, 2001·6 cites·6 claims
- 2257US6274335B1Method of treatment using recombinant human tissue plasminogen activatorGENENTECH INC·Filed 1998·Granted Aug 14, 2001·6 cites·14 claims
- 2357US5219569AProtease resistant urokinaseGENENTECH INC·Filed 1985·Granted Jun 15, 1993·9 cites·11 claims
- 2455US5869314ATissue plasminogen activators and derivatives thereof as produced by recombinant meansGENENTECH INC·Filed 1995·Granted Feb 9, 1999·8 cites·13 claims
- 2555US5587159AHuman tissue plasminogen activatorGENENTECH INC·Filed 1994·Granted Dec 24, 1996·9 cites·4 claims
- 2653US7084251B1Methods and Deoxyribonucleic acid for the preparation of tissue factor proteinGENENTECH INC·Filed 1995·Granted Aug 1, 2006·8 cites·21 claims
- 2750US5728566ATissue plasminogen activator derivativesGENENTECH INC·Filed 1995·Granted Mar 17, 1998·4 cites·4 claims
- 2849US5714372ATissue plasminogen activator variantsGENENTECH INC·Filed 1994·Granted Feb 3, 1998·9 cites·7 claims
- 2947US5728565AMethods of preparing tissue plasminogen activator derivativesGENENTECH INC·Filed 1994·Granted Mar 17, 1998·6 cites·8 claims
- 3047US5424198AHuman tPA production using vectors coding for DHFR proteinGENENTECH INC·Filed 1993·Granted Jun 13, 1995·6 cites·8 claims
- 3147US5011795AHuman tPA production using vectors coding for DHFR proteinGENENTECH INC·Filed 1990·Granted Apr 30, 1991·8 cites·10 claims
- 3244US5702938AHuman tissue plasminogen activatorGENENTECH INC·Filed 1995·Granted Dec 30, 1997·2 cites·4 claims
- 3343US6261837B1Human tPA production using vectors coding for DHFR proteinGENENTECH INC·Filed 1998·Granted Jul 17, 2001·3 cites·5 claims
- 3443US5762921AComposition and methods for the treatment of tumorsGENENTECH INC·Filed 1996·Granted Jun 9, 1998·6 cites·18 claims
- 3540US6994988B1Methods and deoxyribonucleic acid for the preparation of tissue factor proteinGENENTECH INC·Filed 1995·Granted Feb 7, 2006·3 cites·14 claims
- 3640US5268291AHuman t-PA production using vectors coding for DHFR proteinGENENTECH INC·Filed 1991·Granted Dec 7, 1993·3 cites·7 claims
- 3738US5736134ATissue plasminogen activator variantsGENENTECH INC·Filed 1992·Granted Apr 7, 1998·3 cites·20 claims
- 3836US5849574AHuman tPA production using vectors coding for DHFR proteinGENENTECH INC·Filed 1995·Granted Dec 15, 1998·1 cites·1 claims
- 3934US7049131B1Methods and deoxyribonucleic acid for the preparation of tissue factor proteinGENENTECH INC·Filed 1995·Granted May 23, 2006·2 cites·22 claims
- 4030US5763253AMethods of preparing tissue plasiminogen activator derivative compositionGENENTECH INC·Filed 1995·Granted Jun 9, 1998·0 cites·8 claims
- 4130US5756093ATissue plasminogen activator variantsGENENTECH INC·Filed 1994·Granted May 26, 1998·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Gordon A. Vehar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →